In vitro and in vivo experiments have demonstrated that activation of the EGFR pathway leads to cyst development [5, 6], whereas pharmacological targeting of the EGFR pathway resulted in reduced kidney growth in animals models [7, 8]. This evidence concerns the gene EGFR and cyst.